Ultragenyx Pharmaceutical Inc. (RARE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Ultragenyx Pharmaceutical Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$17.20
+2.69% today
Market cap
$1.7B
Overall quality
—
Kronos AI 30-day
+14.0%
7 of 8 simulated paths end higher
Ultragenyx Pharmaceutical Inc. (RARE) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.7B. It trades at $17.20, up 2.69% today. 21 analysts' average target of $26.25 implies +52.6% from today's price. Kronos AI's 30-day forecast is +14.0% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $26.25 |
| Low – high | $16.00 – $39.00 |
| Analysts | 21 |
| Upside to average | +52.6% |
Kronos AI 30-day forecast
| Expected close | $19.10 (+14.0%) |
| Likely range | +5.7% … +34.5% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.